Haleos Labs Limited EPS

Haleos Labs Limited EPS

Image

Haleos Labs Limited

NSE: HALEOSLABS

EPS

₹ 65.65

Last updated on: Mar 09, 2026

Key Highlights

  • The Earning per Share of Haleos Labs Limited is ₹ 65.65 as of 09 Mar 26 The earning per share of Haleos Labs Limited changed from ₹ 23.15 to ₹ 21.89 over 7 quarters. This represents a CAGR of -3.15% .

Historical Earning per Share of Haleos Labs Limited

No data available

* All values are in

Company Fundamentals for Haleos Labs Limited

Market Cap

386 Cr

EPS

65.7

P/E Ratio (TTM)

19.5

P/B Ratio (TTM)

1.9

Day’s High

1319.5

Day’s Low

1278.0

DTE

0.3

ROE

9.1

52 Week High

1680.0

52 Week Low

956.05

ROCE

12.3

Market Price of Haleos Labs Limited

1M

1Y

3Y

5Y

Monitoring Haleos Labs Limited share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
09 Mar 20261280
06 Mar 20261282
05 Mar 20261272
04 Mar 20261294.65
02 Mar 20261275
27 Feb 20261316
26 Feb 20261318.9
25 Feb 20261282.5
17 Feb 20261349.95
13 Feb 20261355.75

SWOT Analysis Of Haleos Labs Limited

Strength

3

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Haleos Labs Limited

Asset Value vs Market Value of Haleos Labs Limited

Market Value

387

Asset Value

Value addition

1.3 X

166

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Haleos Labs Limited386.98
Sun Pharmaceutical Industries Ltd433704
Divis Laboratories Ltd168223
Torrent Pharmaceuticals Ltd147928
Dr Reddys Laboratories Ltd107368
Cipla Ltd107043

Historical Market Cap of Haleos Labs Limited

No data available

* All values are in crore

Historical Revenue of Haleos Labs Limited

No data available

* All values are in crore

Historical EBITDA of Haleos Labs Limited

No data available

* All values are in crore

Historical Net Profit of Haleos Labs Limited

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Haleos Labs Limited News Hub

SMS LifeSciences India AGM scheduled

SMS LifeSciences India announced that the 18th Annual General Meeting (AGM) of the company will be h

Read more

20 Aug 24

SMS Lifesciences India reports consolidated net profit of Rs 7.00 crore in the June 2024 quarter

Net profit of SMS Lifesciences India reported to Rs 7.00 crore in the quarter ended June 2024 as aga

Read more

09 Aug 24

SMS LifeSciences India schedules board meeting

SMS LifeSciences India will hold a meeting of the Board of Directors of the Company on 9 August 2024

Read more

08 Aug 24

SMS LifeSciences India to announce Quarterly Result

SMS LifeSciences India will hold a meeting of the Board of Directors of the Company on 29 May 2025.

Read more

24 May 25

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Haleos Labs Limited

What is the EPS of Haleos Labs Limited stock?

The Earnings Per Share (EPS) of Haleos Labs Limited is 65.65. An EPS is the amount of net income attributed to each share of a common stock.

How is Haleos Labs Limited EPS calculated?

The EPS of Haleos Labs Limited is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Haleos Labs Limited report its EPS?

Haleos Labs Limited typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Haleos Labs Limited EPS?

Factors that influence the EPS of Haleos Labs Limited include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Haleos Labs Limited EPS growth indicate future performance?

Yes, consistent growth in Haleos Labs Limited EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions